1. Home
  2. USBC vs TNYA Comparison

USBC vs TNYA Comparison

Compare USBC & TNYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

USBC

USBC Inc.

N/A

Current Price

$0.35

Market Cap

221.2M

Sector

N/A

ML Signal

N/A

Logo Tenaya Therapeutics Inc.

TNYA

Tenaya Therapeutics Inc.

N/A

Current Price

$0.74

Market Cap

178.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
USBC
TNYA
Founded
N/A
2016
Country
United States
Employees
24
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
221.2M
178.5M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
USBC
TNYA
Price
$0.35
$0.74
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$5.33
AVG Volume (30 Days)
260.3K
5.2M
Earning Date
N/A
03-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
54.96
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$1,456.12
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.35
$0.36
52 Week High
$1.97
$2.35

Technical Indicators

Market Signals
Indicator
USBC
TNYA
Relative Strength Index (RSI) 42.17 47.51
Support Level $0.35 $0.61
Resistance Level $0.42 $0.75
Average True Range (ATR) 0.03 0.10
MACD 0.01 -0.01
Stochastic Oscillator 30.36 33.90

Price Performance

Historical Comparison
USBC
TNYA

About USBC USBC Inc.

USBC Inc is a multi-disciplinary technology company that is an innovator in digital financial technologies. The company develops financial services including digital assets and banking solutions, as well as non-invasive health monitoring research. USBC has implemented a Bitcoin treasury strategy to support development and research across its various divisions. A key focus is the further development of its tokenized deposit program, a tokenized representation of a U.S.-dollar-denominated bank deposit account that operates on blockchain technology and is embedded with digital identity, alongside its legacy non-invasive sensor technology business, with the objective of creating long-term shareholder value in an evolving financial landscape.

About TNYA Tenaya Therapeutics Inc.

Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.

Share on Social Networks: